ITU Unit Action

JELMYTO

UROGEN PHARMA LTD.

ITU Unit Action

Trademark Snap Shot ITU Unit Action
(Table presents the data on ITU Unit Action)

OVERVIEW

SERIAL NUMBER 88204510 FILING DATE 11/25/2018
REG NUMBER 0000000 REG DATE N/A
REGISTER PRINCIPAL MARK TYPE TRADEMARK
INTL REG # N/A INTL REG DATE N/A
TM ATTORNEY LORENZO, GEORGE M
L.O. ASSIGNED 101

PUB INFORMATION

RUN DATE 06/23/2020
PUB DATE 04/09/2019
STATUS 819-SU - REGISTRATION REVIEW COMPLETE
STATUS DATE 06/22/2020
LITERAL MARK ELEMENT JELMYTO

DATE ABANDONED N/A DATE CANCELLED N/A
SECTION 2F NO SECTION 2F IN PART NO
SECTION 8 NO SECTION 8 IN PART NO
SECTION 15 NO REPUB 12C N/A
RENEWAL FILED NO RENEWAL DATE N/A
DATE AMEND REG N/A


FILING BASIS

FILED BASIS CURRENT BASIS AMENDED BASIS
1 (a) NO 1 (a) YES 1 (a) NO
1 (b) YES 1 (b) NO 1 (b) NO
44D NO 44D NO 44D NO
44E NO 44E NO 44E NO
66A NO 66A NO

NO BASIS NO NO BASIS NO


MARK DATA

STANDARD CHARACTER MARK YES
LITERAL MARK ELEMENT JELMYTO
MARK DRAWING CODE 4-STANDARD CHARACTER MARK
COLOR DRAWING FLAG NO

CURRENT OWNER INFORMATION

PARTY TYPE 20-OWNER AT PUBLICATION
NAME UROGEN PHARMA LTD.
ADDRESS 9 HaTa'asiya Street
Ra'anana, 4365007
ENTITY 11-COMPANY
CITIZENSHIP Israel

GOODS AND SERVICES

INTERNATIONAL CLASS 005
          DESCRIPTION TEXT Pharmaceutical preparations and compositions for the treatment of urinary tract cancer

GOODS AND SERVICES CLASSIFICATION

INTERNATIONAL CLASS 005 FIRST USE DATE 05/18/2020 FIRST USE IN COMMERCE DATE 05/18/2020 CLASS STATUS 6-ACTIVE

MISCELLANEOUS INFORMATION/STATEMENTS

CHANGE IN REGISTRATION NO

PROSECUTION HISTORY

DATE ENT CD ENT TYPE DESCRIPTION ENT NUM
06/23/2020 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED 022
06/22/2020 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED 021
06/22/2020 SUPC I STATEMENT OF USE PROCESSING COMPLETE 020
05/29/2020 IUAF S USE AMENDMENT FILED 019
06/18/2020 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL 018
05/29/2020 EISU I TEAS STATEMENT OF USE RECEIVED 017
10/26/2019 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED 016
10/24/2019 EX1G S EXTENSION 1 GRANTED 015
10/24/2019 EXT1 S EXTENSION 1 FILED 014
10/24/2019 EEXT I TEAS EXTENSION RECEIVED 013
06/27/2019 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED 012
06/27/2019 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED 011
06/04/2019 NOAM O NOA MAILED - SOU REQUIRED FROM APPLICANT 010
04/29/2019 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED 009
04/29/2019 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED 008
04/09/2019 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED 007
04/09/2019 PUBO A PUBLISHED FOR OPPOSITION 006
03/20/2019 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED 005
02/28/2019 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER 004
02/26/2019 DOCK D ASSIGNED TO EXAMINER 003
12/13/2018 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM 002
11/28/2018 NWAP I NEW APPLICATION ENTERED IN TRAM 001

CURRENT CORRESPONDENCE INFORMATION

ATTORNEY Peter J. Willsey
CORRESPONDENCE ADDRESS Peter J. Willsey
Brown Rudnick LLP
601 Thirteenth Street NW Suite 600
Washington, DC 20005
DOMESTIC REPRESENTATIVE Peter J. Willsey

PRIOR OWNER INFORMATION

PARTY TYPE 10-ORIGINAL APPLICANT
NAME UROGEN PHARMA LTD.
ADDRESS 13 HASADNA STREET
RA'ANANA, 
ENTITY 11-COMPANY
CITIZENSHIP Israel

ITU Unit Action [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed